RESEARCH TRIANGLE PARK, N.C.--(EON: Enhanced Online News)--95% of surveyed pharmaceutical companies employ a centralized speaker program structure, positioned either under the corporate structure or business unit level, found a recent Cutting Edge Information study.
“Promotional Speaker Programs: Successfully Managing Speaker Bureaus and Recruiting Thought Leaders”
The study, “Promotional Speaker Programs: Successfully Managing Speaker Bureaus and Recruiting Thought Leaders,” found that 40% of pharmaceutical and medical device executives reported housing centralized speaker programs at both the corporate and business unit levels.
According to the data, companies balance centralized and decentralized speaker program structures. Most Top 10 companies favor centralization at the business unit or therapeutic area level and decentralization at the country level. By comparison, many Top 50 companies favor a centralized speaker program at the corporate level combined with a centralized program at either the business unit or therapeutic area level. A Top 50 company executive leveraged his centralized speaker program structure to conduct more than 275 individual programs last year.
All but one surveyed small pharmaceutical company report centralizing their speaker program structure at the corporate level. However, speaker program structures at surveyed medical device companies are more varied. Like surveyed small companies, several device companies centralize their speaker programs at the corporate level.
Although centralizing at corporate or business unit levels, pharmaceutical and medical device companies may also decentralize at the country level. Among companies surveyed, seven reported having decentralized structures at the country level. Of these, 57% reported centralizing either the corporate or the business-level structures in their organizations. Roughly 28% of companies with country level decentralization also reported centralization at both corporate and business levels.
“Promotional Speaker Programs: Successfully Managing Speaker Bureaus and Recruiting Thought Leaders” (http://www.cuttingedgeinfo.com/research/marketing/pharma-speaker-programs/) features detailed data on the impact of regulatory changes to promotional speaker program teams. Research includes metrics illustrating speaker event management including typical attendance, average cost per attendee and best times to hold events.
Use this report to:
- Understand and adapt to the impact of the Sunshine Act on speaker programs.
- Allocate funding and cross-functional staff to best support promotional speaker program teams.
- Gather fair-market value benchmarks for speakers’ compensation.
For more information about pharmaceutical speaker program benchmarks, contact Cassie Demeter at 919-403-6583.